Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2018-08-01
2020-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Dual Task Training in Elderly With Cognitive Decline
NCT04689776
Effects of SUDOKU Mind Activation & Revitalizing Training on Cognitive Function in People With Mild Cognitive Impairment
NCT04913857
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
NCT03403257
Cognitive Training to Promote Brain Health: Implementation and Engagement
NCT03408509
Dual-task Exercise in People With Cognitive Impairment
NCT06389812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Duolingo Spanish Course
30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
Duolingo
Will learn Spanish using the commercially available Duolingo application. It is a computerized language training program.
BrainHQ
30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
BrainHQ
Will use the commercially available Posit Science product Brain HQ. Brain HQ is a computerized adaptive cognitive brain training program.
Passive Control
No intervention.
Passive Control
No Intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Duolingo
Will learn Spanish using the commercially available Duolingo application. It is a computerized language training program.
BrainHQ
Will use the commercially available Posit Science product Brain HQ. Brain HQ is a computerized adaptive cognitive brain training program.
Passive Control
No Intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must be able to travel to Baycrest by personal or study-arranged automobile, or public transportation.
* Participants must be monolingual native English speakers.
* Participants must be willing to provide informed consent.
* Participants must have daily access to a smartphone/mobile device.
* Have not previously studied Spanish formally, nor any other language in the past 10 years.
Exclusion Criteria
* meet DSM-IV-TR criteria for Axis I mood, anxiety, or psychotic or substance abuse disorders.
* Fluent in more than one language.
65 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Rotman Research Institute at Baycrest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jed A. Meltzer, Ph.D
Neurorehabilitation Scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baycrest Health Sciences
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I2P2-2-00140
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.